Liquid chromatographic method for determination of free and niosome-entrapped nimodipine in mouse plasma and different tissues

Analytical Letters

Volumn 41, Issue 4, 2008, Pages 533-542

  Dan Bo, Yang ^a   Jia Bi, Zhu ^a   Rui Qin, Lv ^a   Zhi Qiang, Hu ^a   Jin Qiu, Shen ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Homogenates; HPLC; Nimodipine; Plasma

Indexed keywords

EID: 41549118585     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710801912441     Document Type: Article

References (17)

1. Chen, M.Y., Shi, X.J., Wang, P., Wang, H.T., Zhang, J.H., and Zhang, L.L. 1999. Determination of nimodipine in plasma by solid-phase extraction - HPLC. Chin. J. Clin. Pharm., 8: 36-39.
2. Dorsch, N.W. 2002. Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr. Opin. Crit. Care., 8: 128-133.
3. Fischer, C., Schonberger, F., Muck, W., Heuck, K., and Eichelbaum, M. 1993. Simultaneous assessment of the intravenous and oral disposition of the enantiomers of racemic nimodipine by chiral stationary-phase high-performance liquid chromatography and gas chromatography/mass spectroscopy combined with a stable isotope technique. J. Pharm. Sci., 82: 244-250.
4. Food and Drug Administration 2001. Guidance for Industry on Bioanalytical Method Validation; U.S. Department of Health and Human Services. Federal Register.
5. Hunter, C.A., Dolan, T.F., Coombs, G.H., and Baillier, A.J. 1988. Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis. J. Pharm. Pharmacol., 40: 161-165.
6. Jackobsen, P., Mikkelsen, E.O., Laursen, J., and Jensen, F. 1986. Determination of nimodipine by gas chromatography using electron capture detection; external factors influencing nimodipine concentration during intravenous administration. J. Chromatogr. B, 374: 383-387.
7. Lalloo, A., Chao, P.Y., Hu, P.D., Stein, S., and Sinko, P.J. 2006. Pharmacokinetic and pharmacodynamic evaluation of a novel in situ forming poly(ethylene glycol)-based hydrogel for the controlled delivery of the camptothecins. J. Control. Release, 112: 333-342.
8. Laslo, A.M., Eastwood, J.D., Urquhart, B., Lee, T.Y., and Freeman, D. 2004. Subcutaneous administration of nimodipine improves bioavailability in rabbits. J. Neurosci. Methods, 139: 195-201.
9. Mück, W.M. 1995. Enantiospecific determination of nimodipine in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A, 712: 45-53.
10. Qiu, F., Chen, X.Y., Li, X.Y., and Zhong, D.Y. 2004. Determination of nimodipine in human plasma by a sensitive and selective liquid chromatography-tandem mass spectrometry method. J. Chromatogr. B, 802: 291-297.
11. Rentel, C.O., Bouwstra, J.A., Naiskett, B., and Junginger, H.E. 1999. Niosomes as a novel peroral vaccine delivery system. Int. J. Pharm., 186: 161-167.
12. Schier, H. and Bouwstra, J. 1994. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J. Contr. Rel., 30: 1-15.
13. Sihorkar, V. and Vyas, S.P. 2000. Polysaccharide coated niosomes for oral drug delivery: formulation and in vitro stability studies. Pharmazie, 55: 107-113.
14. Teixeira, R.S., Curi, R., and Maranhao, R.C. 2004. Effects on Walker 256 tumour of carmustine associated with a cholesterol-rich microemulsion (LDE). J. Pharm. Pharmacol., 56: 909-914.
15. Uchegbu, I.F., Double, J.A., Turter, J.A., and Florence, A.J. 1995. Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monostearate (Span 60) niosomes in the mouse. Pharm. Res., 12: 1019-1024.
16. Vadiei, K., Roman, P.S., Gabriel, L.B., and Luke, D.R. 1989. Pharmacokinetic and pharmacodynamic evaluation of liposomal cyclosporine. Int. J. Pharm., 57: 125-131.
17. Zhang, Q.Z., Jiang, X.G., Jiang, W.M., Lu, W., Su, L.N., and Shi, Z.Q. 2004. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. Int. J. Pharm., 275: 85-96.